INJE PharmacoGenomics Research Center

· Moon JJ, Kim HS, Shim JC, Ahn JM, Jung DU, Kim DJ, Jeong HE, Kim EY, Jeon DW, Kim SJ, Shin JG

Possible genetic biomarker associated with antipsychotic-induced amenorrhea in female patients with schizophrenia (cPMTb)

Int Clin Psychopharmacol. 1;39(1):29-35 / 2024.01 [LINK]

· Parvez MM, Kalkisim S, Nguyen PTT, Jung JA, Park JK, Ghim JL, Kim EY, Cho YS, Babaoglu MO, Shin JG

Para-aminosalicylic acid significantly reduced tenofovir exposure in human subjects: Mismatched findings from in vitro to in vivo translational research (cPMTb)

Br J Clin Pharmacol. 88(3):1159-1169 / 2022.03 [LINK]

· Parvez MM, Kalkisim S, Nguyen PTT, Jung JA, Park JK, Ghim JL, Kim EY, Cho YS, Babaoglu MO, Shin JG

Para-aminosalicylic acid significantly reduced tenofovir exposure in human subjects: Mismatched findings from in vitro to in vivo translational research (cPMTb)

Br J Clin Pharmacol. 88(3):1159-1169 / 2022.03 [LINK]

· Kim EY, Choi SJ, Ghim JL, Kim MY, Seol JE, Oh MK, Park CS, Shin JG

Associations between HLA-A, -B, and -C alleles and iodinated contrast media-induced hypersensitivity in Koreans (cPMTb)

Transl Clin Pharmacol. 29(2):107-116 / 2021.06 [LINK]

· Kim EY, Kim MY, Park CS, Choi JH, Ghim JL, Kim HS, Shin JG*

Antiepileptic drug-induced severe cutaneous adverse reactions and HLA alleles: A report of five cases with lymphocyte activation test (cPMTb)

Transl Clin Pharmacol. 27(2):64-68 / 2019.06 [LINK]

· Ghim JL, Nguyen PTT, Kim MJ, Kim EJ, Song GS, Ahn SZ, Shin JG, Kim EY

Pharmacokinetics of fixed-dose combination of atorvastatin and metformin compared with individual tablets (cPMTb)

Drug Des Devel Ther. 13:13:1623-1632/ 2019.05 [LINK]

· Kim HS, Oh MK, Kim EJ, Song GS, Kim EY, Shin JG

Pharmacodynamic effects of voglibose administered alone, administered with metformin and administered with metformin in a fixed-dose combination in healthy Korean subjects (cPMTb)

Int J Clin Pharmacol Ther. 56(11):544-550 / 2018.11 [LINK]

· Oh MK, Ghim JL, Park SE, Kim EY, Shin JG

Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of fimasartan, amlodipine, and rosuvastatin using partial replicated design in healthy adult subjects (cPMTb)

Drug Des Devel Ther. 8:12:1157-1164 / 2018.05 [LINK]

· Kim HS, Chang K, Koh YS, Park MW, Choi YS, Park CS, Oh M, Kim EY, Shon JH, Shin JG, Seung KB.

CYP2C19 poor metabolizer is associated with clinical outcome of clopidogrel therapy in acute myocardial infarction but not stable angina. (BMRC, PRCDM)

Circ Cardiovasc Genet. 6(5):514-21 / 2013.10 [LINK]

2013-International

· Jiang F, Yeo CW, Lee SS, Oh MK, Ghim JL, Shon JH, Kim HS, Kim EY, Kim DH, Shin JG.

Effect of HNF4α genetic polymorphism G60D on the pharmacokinetics of CYP2D6 substrate tolterodine in healthy Korean individuals. (BMRC)

Pharmacogenet Genomics. 23(3):175-9 / 2013.03 [LINK]

2013-International

Publications

Product